Skip to main content
. 2023 Jan 5;12(1):2161167. doi: 10.1080/2162402X.2022.2161167

Figure 2.

Figure 2.

Immunoscore (IS) and clinical outcomes of patients with stage II CRC. Overall recurrence rates according to the IS 3-groups (a) and the modified IS 2-groups (c). Kaplan-Meier curves for disease-free survival (DFS) according to IS 3-groups (b) and the modified IS 2-groups (d). Kaplan-Meier curves for DFS in patients with different clinical risk and IS levels (e). Kaplan-Meier curves for DFS in untreated patients with different clinical risk and IS levels (f). Hi, high; Int, intermediate; Lo, low; (*) indicates significant log-rank P-value, *< .05, **< .01, ***< .001; ns, non-significant.